BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) granted the Company's previously announced application for the imposition of a management cease trade order under National Policy 12-203 – Management Cease Trade Orders. The Company made the application in connection with its default with respect to having not filed its audited annual financial statements for the year ended October 31, 2023. A further factor contributing to the delay is the recent unexpected departures of the